LATISSE™
eyelash treatment is here
Now you
can grow your own longer, fuller, darker eyelashes with an
FDA approved treatment that
really works. These photos
show results before and after 16 weeks of using LATISSE™.
LATISSE™
(bimatoprost ophthalmic solution) 0.03% is the first and only
prescription treatment approved by the FDA for inadequate
or insufficient eyelashes, growing them longer, fuller and
darker.
LATISSE™
makes lash growth possible because of its active ingredient:
bimatoprost. Although the precise mechanism of action is not
known, research suggests that lashes can grow longer, thicker
and darker beacuse bimatoprost may increase the percent of
hairs in the growth phase, as well as prolong the duration
of the growth phase.
LATISSE™
is easy to use, FDA approved
and effective. It's a once-a-day treatment you apply topically
to the base of your upper eyelashes using an eyeliner type
brush that comes with the kit. Patients in a clinical trial
saw results gradually over time (starting at 4 weeks with
full results after 16 weeks). The FDA study showed that eyelashes
typically grew 25 percent longer,
106 percent thicker and 18 percent darker.
LATISSE™
is an innovation backed by research. While LATISSE™ is
a new treatment in eyelash growth, it was developed through
years of research by Allergan, a pharmaceutical leader with
over 60 years of expertise in prescription eye care products.
Have questions
about LATISSE™? Check out our frequently
asked questions or call 310.247.3777 for more information.
Dr.
Jonathan Hoenig, a Los Angeles, California facial plastic
surgeon is an expert in aesthetic facial surgery and non-
surgical enhancement. As an ophthalmologist and oculplastic
surgeon, he has been prescribing bimatoprost ophthalmic solution
for nearly 20 years! Experience matters.
We welcome
you to contact
us today at in Beverly Hills or Sherman Oaks for more
information, and to find out if LATISSE™ is right for
you.
And don't
forget to sign up for our mailing
list for a FREE report on "10 ways to reduce facial
aging", to receive special newsletter only offers, and
to stay updated on the latest news in eyelid and facial cosmetic
enhancement.
|
